Janić, M.; Škrgat, S.; Harlander, M.; Lunder, M.; Janež, A.; Pantea Stoian, A.; El-Tanani, M.; Maggio, V.; Rizzo, M.
Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at? Medicina 2024, 60, 2030.
https://doi.org/10.3390/medicina60122030
AMA Style
Janić M, Škrgat S, Harlander M, Lunder M, Janež A, Pantea Stoian A, El-Tanani M, Maggio V, Rizzo M.
Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at? Medicina. 2024; 60(12):2030.
https://doi.org/10.3390/medicina60122030
Chicago/Turabian Style
Janić, Miodrag, Sabina Škrgat, Matevž Harlander, Mojca Lunder, Andrej Janež, Anca Pantea Stoian, Mohamed El-Tanani, Viviana Maggio, and Manfredi Rizzo.
2024. "Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?" Medicina 60, no. 12: 2030.
https://doi.org/10.3390/medicina60122030
APA Style
Janić, M., Škrgat, S., Harlander, M., Lunder, M., Janež, A., Pantea Stoian, A., El-Tanani, M., Maggio, V., & Rizzo, M.
(2024). Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at? Medicina, 60(12), 2030.
https://doi.org/10.3390/medicina60122030
